Dynavax Technologies reported $126K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Adma Biologics ADMA:US $ 0.02M 0M
Agenus AGEN:US $ 2.83M 0.16M
Amgen AMGN:US $ 31343M 96M
AstraZeneca AZN:LN 387M 0M
Astrazeneca AZN:US $ 387M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Chimerix CMRX:US $ 0.09M 0M
Dynavax Technologies DVAX:US $ 0.13M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Idera Pharmaceuticals IDRA:US $ 0.05M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 890M 11M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M